The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law BPC 157: Miracle Healing Peptide or Hidden Danger? RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157: Experimental Peptide Creates Risk for Athletes FDA takes first step in possible reversal of ban on some peptides The Washington Post